US Bancorp’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
B
CS
CH
US Bancorp's CLLS Position: Q1 2023 in Review
US Bancorp sold out of Cellectis (CLLS) in Q1 2023, closing a stake of 10 shares — an estimated $21 sold.
US Bancorp first reported a position in CLLS in Q2 2018 and held it in 17 quarters. The position peaked at $53K in Q4 2020. 34 funds tracked by Wall St. Rank hold CLLS as of Q1 2023.
- US Bancorp reported no remaining Cellectis position as of Q1 2023 after selling out during the quarter.
- US Bancorp sold 10 Cellectis shares in Q1 2023, an estimated $21.
- US Bancorp first reported a position in Cellectis in Q2 2018 and held it in 17 quarters.
- US Bancorp's Cellectis position peaked at $53K in Q4 2020.
- 34 funds tracked by Wall St. Rank held Cellectis as of Q1 2023.
Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.